Dr. Movva on Chemotherapy Administration and Survival in Soft Tissue Sarcoma

Chemotherapy Toxicity Considerations in Soft Tissue SarcomaПодробнее

DMSOG Sarcoma Classes #6: Chemotherapy for Soft Tissue Sarcomas-by Dr Sameer RastogiПодробнее

Dr. Tap on Olaratumab in Patients With Soft Tissue SarcomaПодробнее

AL3818 hydrochloride monotherapy in subjects with metastatic or advanced synovial sarcomaПодробнее

Dr. Secord on the Management of Patients With SarcomaПодробнее

Chemotherapy Sensitivity in Soft Tissue SarcomaПодробнее

Dr. Lazarides on Margin Assessment in SarcomaПодробнее

Benefits of adjuvant chemo for soft tissue sarcoma patientsПодробнее

Kenneth Cardona, MD on treating sarcomaПодробнее

Know What Your Doctors Know: Soft Tissue Sarcoma Q&A – Chemo effectiveness in metastatic sarcomaПодробнее

Dr. Philip on Olaratumab for Soft Tissue SarcomaПодробнее

Management of Refractory Soft Tissue Sarcoma Speaker: Dr. Kanaan AlshammariПодробнее

Advances in Therapy for Sarcomas & GISTПодробнее

Dr. Somaiah on CMB305 in Soft Tissue SarcomaПодробнее

Case Disccussion (Soft Tissue Sarcoma/Metastasis) : Moderator: Yogesh PanchwaghПодробнее

Dr. Matthew Hemming on treating sarcomas | Dana-Farber Cancer InstituteПодробнее

Treatment Options For Bone & Soft Tissue Sarcoma | Dr. Trinanjan Basu | HCG BorivaliПодробнее

Management of Oligometastases in Soft-Tissue SarcomaПодробнее

Dr. Gibbs on the Lack of Treatment Options in SarcomaПодробнее